FIELD: medicine.
SUBSTANCE: invention relates to the field of medicine and is intended to predict the high risk of early atherosclerosis. Allelic variants are determined in the patient, selected from the group including Gly482Ser PPARGC1A, Leu28Pro АРОЕ, Lys198Asn EDN, G-250A LIPC and Ser447Ter LPL. If the presence of at least three of these variants is established, a high risk of early atherosclerosis is predicted.
EFFECT: invention provides increased effectiveness of predicting a high risk of early atherosclerosis.
3 cl, 2 dwg, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREDICTING HIGH RISK OF REPRODUCTIVE LOSS IN FIRST TRIMESTER OF PREGNANCY | 2016 |
|
RU2611358C1 |
| METHOD OF DETERMINING PREDISPOSITION TO LONG PHYSICAL EFFORT | 2011 |
|
RU2468086C1 |
| METHOD FOR ASSESSING THE RISK OF DEVELOPING ABDOMINAL OBESITY IN PERSONS WITH VIBRATION DISEASE CAUSED BY EXPOSURE TO LOCAL VIBRATION | 2021 |
|
RU2783252C1 |
| METHOD FOR PREDICTION OF MEN'S RISK OF ESSENTIAL HYPERTENSION ASSOCIATED WITH OBESITY | 2018 |
|
RU2693469C1 |
| METHOD OF GENETIC DIAGNOSTICS OF UNFAVOURABLE OUTCOME IN PATIENTS WITHIN ONE YEAR AFTER ACUTE CORONARY SYNDROME WITH ST SEGMENT ELEVATION | 2012 |
|
RU2502474C1 |
| METHOD FOR PREDICTION OF RISK OF DEVELOPING GENITAL PROLAPSE IN PRE-CLINICAL PAROUS WOMEN | 2023 |
|
RU2826543C1 |
| METHOD FOR EXTENDED SCREENING OF PREDISPOSITION TO CARDIOVASCULAR DISEASES AND BIOCHIP FOR IMPLEMENTING SUCH METHOD | 2010 |
|
RU2453606C2 |
| METHOD FOR FETAL GROWTH RESTRICTION PREDICTION | 2020 |
|
RU2738674C1 |
| METHOD FOR PREDICTION OF RISK OF GENITAL PROLAPSE IN WOMEN | 2023 |
|
RU2823209C1 |
| METHOD OF SCREENING CARDIOVASCULAR DISEASES AND BIOCHIP FOR SAID METHOD REALISATION | 2008 |
|
RU2402771C2 |
